I'm hosting Pharmacogenomics & Pharmacovigilance in Precision Medicine. Would you like to attend? 
LATEST NEWS
February 6, 2021
Regeneron Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has announced financial results for the fourth quarter and full year 2020 and provided a business update. “In 2020,...
Read More
February 4, 2021
Thermo Fisher Scientific and JW Therapeutics Announce CAR-T Partnership in China
Thermo Fisher Scientific, the world leader in serving science, has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exclusive...
Read More
February 4, 2021
Merck KGaA, Darmstadt, Germany, Announces Leadership Change for North America and Global Innovative Medicine Franchises in Healthcare
Merck KGaA, Darmstadt, Germany, which operates its Healthcare business sector as EMD Serono in the US and Canada, today announced that Rehan Verjee has...
Read More
February 4, 2021
Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year...
Read More
February 4, 2021
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, announces a collaboration with Gabriel Precision...
Read More
February 4, 2021
23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics
23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group,...
Read More
